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 2
Abstract 20 
Bovine herpesvirus 1 (BHV-1) establishes a life-long latent infection in sensory neurons 21 
following acute infection. Increased corticosteroid levels, due to stress, increases the incidence of 22 
reactivation from latency.  Within minutes, corticosteroids activate the glucocorticoid receptor 23 
and transcription of promoters containing a glucocorticoid receptor element.  A single 24 
intravenous injection of the synthetic corticosteroid dexamethasone consistently induces 25 
reactivation from latency in calves.  Lytic cycle viral gene expression is detected within 6 hours 26 
after dexamethasone treatment of calves latently infected with BHV-1.  Cellular transcription 27 
factors are induced by dexamethasone in trigeminal ganglionic neurons within 1.5 hours after 28 
dexamethasone treatment suggesting they promote viral gene expression during the early phases 29 
of reactivation from latency, which we operationally defined as the escape from latency.  In this 30 
study, immunohistochemistry was utilized to examine viral protein expression during the escape 31 
from latency.  Within 1.5 hours after dexamethasone treatment, bICP0 and a late protein (VP16) 32 
were consistently detected in a subset of trigeminal ganglionic neurons.  Most neurons 33 
expressing bICP0 also expressed VP16.  Additional studies revealed that neurons expressing the 34 
glucocorticoid receptor also expressed bICP0 or VP16 at 1.5 hours after dexamethasone 35 
treatment.  Two other late proteins, glycoprotein C and D, were not detected until 6 hours after 36 
dexamethasone treatment and were detected in only a few neurons.  These studies provide 37 
evidence that VP16 and the promiscuous viral trans-activator (bICP0) are expressed during the 38 
escape from latency suggesting they promote the production of infectious virus in a small subset 39 
of latently infected neurons. 40 
  41 
 3
INTRODUCTION 42 
Bovine herpesvirus 1 (BHV-1) induces clinical disease in the upper respiratory tract, 43 
nasal cavity, or ocular cavity of cattle.  BHV-1 establishes latency in sensory neurons, but 44 
periodically reactivates from latency, and consequently is widespread in cattle (31-33, 36).  45 
Infection inhibits cell-mediated immunity (4, 17-19), CD8+ T cell recognition of infected cells 46 
(21, 25, 41, 51), and induces apoptosis in CD4+ T cells (12, 74). Two viral regulatory proteins, 47 
bICP0 and bICP27, inhibit interferon dependent transcription (6, 22, 33, 61, 62).  Infection also 48 
erodes mucosal surfaces within the upper respiratory tract, which promotes establishment of 49 
bacterial pathogens in the lower respiratory tract (23, 24, 83).   50 
 51 
The incidence of BHV-1 reactivation from latency is increased following stressful stimuli 52 
that increase corticosteroid levels, reviewed in (34, 37, 56).  Regardless of the reactivation 53 
stressor, lytic cycle viral gene expression, which is nearly undetectable during latency, must be 54 
activated. Administration of the synthetic corticosteroid dexamethasone (DEX) to latently 55 
infected calves or rabbits initiate BHV-1 reactivation from latency 100% of the time (28, 31, 32, 56 
35, 36, 60). Six hours after DEX treatment lytic cycle viral RNA expression is readily detected in 57 
a subset of trigeminal ganglionic neurons of latently infected calves (73, 76).  DEX treatment of 58 
latently infected calves induces apoptosis of T cells that persist in trigeminal ganglia (TG) after 59 
infection (73).  T cells also persist in TG of humans or mice latently infected with HSV-1 (3, 20, 60 
46, 64-66, 69) and are proposed to promote the maintenance of latency (38, 40, 43-45, 59).   61 
 62 
Within 3 hours after calves latently infected with BHV-1 are treated with DEX, 11 63 
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cellular genes are induced more than ten fold in TG (80).  Pentraxin 3, a regulator of innate 64 
immunity and neuro-degeneration, is stimulated 35-63 fold at 3 or 6 hours after DEX treatment.  65 
Two transcription factors, promyelocytic leukemia zinc finger (PLZF) and Slug are induced 66 
more than 15-fold 3 hours after DEX treatment.  PLZF or Slug stimulates BHV-1 productive 67 
infection 20-fold or 5-fold respectively, and Slug stimulates the late glycoprotein C promoter 68 
more than 10-fold.  Additional DEX induced transcription factors, SPDEF (Sam-pointed domain 69 
containing Ets transcription factor), Kruppel-like transcription factor 15 (KLF15), KLF4, KLF6, 70 
and GATA6, stimulate productive infection and certain key viral promoters.  The DEX inducible 71 
cellular transcription factors are predicted to mediate certain aspects of the early phases of 72 
reactivation from latency, including activation of lytic cycle viral gene expression.  Latently 73 
infected neurons that express detectable levels of lytic cycle viral proteins within six hours after 74 
DEX treatment are operationally defined as escaping latency (80).   75 
 76 
In this study, we examined bICP0, VP16, gC, and gD protein expression during the 77 
escape from latency.  bICP0 and VP16 positive TG neurons were detected at 1.5 hours after 78 
DEX treatment, but were not readily detected prior to DEX treatment.  Consecutive sections 79 
were prepared and subsequent studies demonstrated that bICP0 and VP16 were frequently 80 
detected in the same neuron.  Conversely, gC or gD positive neurons were not detected until 6 81 
hours after DEX treatment, and only a few positive neurons were detected.  At 1.5 hours after 82 
DEX treatment, bICP0 or VP16 and the glucocorticoid receptor (GR) were detected in the same 83 
neuron.  These studies suggest that activation of the GR by DEX directly stimulates lytic cycle 84 
viral gene expression during the escape from latency.   85 
  86 
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MATERIALS AND METHODS 87 
Cells and Virus 88 
Bovine kidney (CRIB) cells were grown in Earle’s modified Eagle’s medium (EMEM) 89 
supplemented with 10% fetal calf serum, penicillin (10 U/ml), and streptomycin (100 μg/ml). 90 
 The Cooper strain of BHV-1 was grown in CRIB cells and was used for all studies.   91 
 92 
Calf studies 93 
All TG samples from calves used for this study were previously described (80).  In brief, 94 
BHV-1-free crossbred calves (~200 kg) were inoculated with 107 PFU of BHV-1 into each 95 
nostril and eye as described previously (28, 29, 47, 53-55).  Calves were housed under strict 96 
isolation and given antibiotics before and after BHV-1 infection to prevent secondary bacterial 97 
infections.  At 60 dpi, calves were injected intravenously (jugular vein) with 100 mg of DEX.  98 
Calves were then transported to the Veterinary Diagnostic lab.  Prior to euthanasia by 99 
electrocution, calves were heavily sedated with Xylazine.  After decapitation, TG were collected, 100 
samples from each TG were formalin fixed and then paraffin embedded.  The remainder of both 101 
TG was minced into small pieces, placed into a single 50 ml conical tube, and the tube placed in 102 
a dry ice ethanol bath.  TG samples were then stored at -80oC.  It took approximately 5 minutes 103 
to collect TG, mince the TG, place TG pieces in a 50 ml conical tube, and submerge the tube in a 104 
dry ice ethanol bath after decapitation.  One calf was decapitated at a time to ensure samples 105 
were processed in a timely manner.  Calves were decapitated in the same order in which they 106 
were injected with DEX to ensure that the time-points after DEX treatment were as close as 107 
possible to the designated time point.  Three calves / time point were used for these studies.  108 
 6
Experiments were performed in accordance with the American Association of Laboratory 109 
Animal Care guidelines and the University of Nebraska IACUC committee.  110 
 111 
Immunohistochemistry  112 
Immunohistochemistry was performed essentially as previously described (49, 50, 73, 113 
75) using the ABC Kit (Vector Laboratories).  In brief, TG from calves were fixed in neutral 114 
buffered formalin, and then embedded in paraffin.  Thin sections (4-5 um) were cut and mounted 115 
onto slides.  Tissue sections were incubated 20 minutes at 65o C followed by two incubations of 116 
10 minutes in xylene and rehydrated in graded alcohols.  Tissue sections were then incubated 117 
with 3% hydrogen peroxide in PBS (pH 7.4) for 20 minutes at room temperature to block 118 
endogenous peroxidase.  After 3 washes in TBS (5 minutes each) at room temperature, tissue 119 
sections were digested with 40 ul of a “ready to use” Proteinase K solution (53020, Dako) for 20 120 
minutes at 37o C to enhance antigen retrieval.  Tissue sections were then blocked with 5% normal 121 
serum diluted in TBS containing 0.25% BSA for 45 minutes at room temperature in a humidified 122 
chamber.  123 
 124 
A peptide specific rabbit antibody was made that is directed against bICP0 (Affinity 125 
Bioreagents, Golden, CO) and the antibody was affinity purified. This antibody specifically 126 
recognizes bICP0 in infected or transfected cells.  A VP16 specific rabbit polyclonal antibody 127 
was obtained from Dr. Vikram Misra (University of Saskatchewan, Saskatoon, CA).  The gC and 128 
gD specific antibodies were obtained from Dr. Shafiqul Chowdhury (Louisiana State University 129 
Veterinary School, Baton Rouge, LA).  The GR specific rabbit polyclonal antibody was 130 
purchased from Santa Cruz Biotechnology (H-300) and was reported to detect the mouse, rat, 131 
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and human protein.  The designated rabbit polyclonal antibodies or the mouse monoclonal 132 
antibodies were used at a 1:500 dilution, incubated overnight in a humidified chamber at 4°C, 133 
and the next day washed in TBS (pH 7.6). Biotinylated goat anti-rabbit IgG (Vector Labs, PK-134 
6101) or biotinylated donkey anti-mouse IgG (Vector Labs, PK-6102) was then incubated with 135 
the section for 30 minutes at room temperature in a humidified chamber.  Next, the avidin-136 
biotinylated enzyme complex was added to slides for 30 minutes at room temperature in a 137 
humidified chamber.  After 3 washes in TBS, slides were incubated with freshly prepared 138 
substrate (Vector Labs, SK-4800), rinsed with distilled water, and counterstained with 139 
hematoxylin.  Thin sections from mock-infected or latently infected calves were used as a 140 
negative control.   141 
 142 
Immunofluorescence to examine GR localization 143 
CRIB cells were incubated in EMEM supplemented with 2% charcoal-stripped FBS at 144 
37°C for 24 hours and then placed on a glass slide for an additional 24 hours. After 2 hours of 145 
DEX treatment (100 nM), cells were fixed in 4% paraformaldehyde for 10 minutes and confocal 146 
microscopy performed. The GR primary antibody (catalogue # 3660; Cell Signaling) was diluted 147 
1:250 in PBS with 0.05% Tween 20 and 1% BSA and incubated on coverslips for 2 hours at 148 
room temperature. After three washes, coverslips were incubated with Alexa Fluor® 488 Goat 149 
Anti-Rabbit IgG (H+L) (A11008; Invitrogen) at a dilution of 1:100 for 1 hour in the dark. After 150 
the slides were washed, DAPI (4’,6-diamidino-2-phenylindole) staining was performed to 151 
visualize the nucleus. Coverslips were then mounted on slides by use of Gelmount aqueous 152 
mounting medium (Electron Microscopy Sciences).  Images were obtained with a Bio-Rad 153 
confocal laser-scanning microscope (MRC-1024ES).   154 
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Western Blot analysis  155 
At the designated times after infection, whole cell lysate was prepared.  Cells were 156 
washed with phosphate-buffered saline (PBS) and suspended in NP-40 lysis buffer (100 mM Tris 157 
{pH 8.0}, 1 mM EDTA, 100 mM NaCl, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, and 158 
one tablet of complete protease inhibitor, Roche Molecular Biochemicals, in 10 ml buffer.  Cell 159 
lysate was incubated on ice for 30 min, sonicated, and then clarified by centrifugation at 10,000 x 160 
g at 4°C for 15 min.  Protein concentrations were quantified by the Bradford assay. For SDS-161 
PAGE, proteins were mixed with an equal amount of 1x sample loading buffer (62.5 mM Tris-162 
HCl {pH 6.8}, 2% sodium dodecyl sulfate, 50 mM dithiothreitol, 0.1% bromophenol blue, 10% 163 
glycerol) and boiled for 5 min. Proteins were separated in an 8 or 12% SDS-PAGE gel. After 164 
electrophoresis, proteins were transferred onto a polyvinylidene difluoride membrane 165 
(Immobilon-P; Millipore) and blocked for 4 hours in 5% nonfat dry milk with Tris-buffered 166 
saline-0.1% Tween 20 (TBS-T).  Membranes were then incubated with primary antibody 167 
overnight at 4o C.  An antibody directed against β-actin (Santa Cruz Biotechnology, Santa Cruz, 168 
CA) was used as a loading control. After 45 minutes of washing with TBS-T, blots were 169 
incubated with donkey anti-rabbit horseradish peroxidase-conjugated immunoglobulin G 170 
(Amersham Biosciences), which was diluted 1:2000 in 5% nonfat milk in TBS-T. Blots were 171 
washed 45 minutes with TBS-T and exposed to Amersham ECL reagents, and then 172 
autoradiography performed. Primary antibodies were described above.  The GR (Cell signaling, 173 
catalogue # 3660), the bICP0, and the VP16 antibody were diluted 1:1,000.  The gC and gD 174 
antibody were diluted 1:500 in blocking buffer.  The secondary donkey anti-rabbit and anti-175 
mouse antibodies were purchased from GE Healthcare.   176 
 177 
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RESULTS 178 
Viral protein expression during productive infection 179 
Initial studies were performed to examine the specificity of BHV-1 antibodies that detect 180 
three late viral proteins (gC, gD, and VP16) and the promiscuous viral trans-activator (bICP0).  181 
The BHV-1 bICP0 mRNA is expressed as an immediate early and early transcript because it 182 
contains an IE and E promoter (77, 78).  For these studies, bovine kidney cells (CRIB) were 183 
infected with BHV-1 using a moi of 2 pfu/cell.  Total cell lysate was prepared at 3, 6, 12, and 24 184 
hours after infection in the absence or presence of the viral DNA polymerase inhibitor PAA.  As 185 
expected, bICP0 was expressed throughout productive infection and PAA had no effect on 186 
expression (Figure 1A, bICP0 panel).  VP16 was not readily detected until 6 hours after infection 187 
and PAA reduced VP16 protein levels.  Expression of the viral glycoprotein gC was not readily 188 
detected until 12 hours after infection and its expression were reduced by PAA treatment.  189 
Conversely, gD expression was detected earlier than VP16 or gC and its expression was not 190 
affected by PAA treatment.  These results are consistent with HSV-1 studies examining the 191 
kinetics of gC, gD, and VP16.  For example, HSV-1 gD is a prototype γ1 gene that is expressed 192 
early during infection and its expression is not dramatically altered by PAA (26, 27).  Conversely, 193 
gC and VP16 are γ2 genes that are expressed relatively late during productive infection, and their 194 
expression is dramatically inhibited by PAA (26, 27).   195 
 196 
CRIB cells infected for 20 hours were fixed in formalin and then confocal microscopy 197 
performed to determine if these antibodies recognized a viral protein in formalin fixed cells.  We 198 
chose a time late after infection because we knew the late proteins would be expressed at readily 199 
detectable levels.  As expected, bICP0 was detected in the nucleus of infected cells; but the other 200 
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three viral proteins were primarily localized to membranes in infected cells (Figure 1B).  None of 201 
the antisera directed against the respective viral proteins recognized a protein in mock-infected 202 
CRIB cells (Mock panel and data not shown).  In summary, these studies demonstrated that the 203 
respective antibodies recognized the expected viral protein by Western Blot analysis and by 204 
confocal microscopy using formalin fixed cells.   205 
 206 
Detection of bICP0 and VP16 during the escape from latency   207 
To test whether viral protein expression can be detected during the escape from latency, 208 
bICP0, VP16, gC, and gD protein expression were examined in TG sections by performing 209 
immunohistochemistry (IHC).  The rationale for examining bICP0 protein expression is that 210 
bICP0 mRNA is consistently detected during DEX induced reactivation from latency (81), and 211 
bICP0 stimulates productive infection and reactivation from latency (14, 15, 31-33, 37).  BHV-1 212 
encoded VP16 may promote the escape from latency because it activates expression of viral IE 213 
genes.  HSV-1 encoded VP16, a late transcript, has been reported to be differentially expressed 214 
in neurons relative to cultured cells and consequently may stimulate reactivation from latency 215 
(39, 71).  TG neurons were recognized by bICP0 or VP16 antiserum (Figure 2) when calves 216 
latently infected with wt BHV-1 were treated with DEX for 1.5 hours. Certain areas of TG 217 
sections contained bICP0 or VP16 positive neurons whereas other areas did not.  As expected, 218 
bICP0 or VP16 positive neurons were not readily detected during latency, and in general fewer 219 
bICP0 or VP16 positive neurons were detected at 3 or 6 hours after DEX treatment relative to 1.5 220 
hours. The number of neurons stained by the gC or gD antiserum was low, and the intensity of 221 
staining was reduced relative to the results obtained with the VP16 or bICP0 antiserum (Figure 222 
3).  We were unable to detect gC or gD prior to 6 hours after DEX treatment (data not shown).  223 
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In contrast to VP16 or bICP0, ORF2+ neurons were readily detected during latency but not six 224 
hours after DEX treatment (67). 225 
 226 
bICP0 and VP16 are frequently expressed in the same neuron during DEX induced 227 
reactivation 228 
 To determine whether bICP0 and VP16 were expressed in the same neuron following 229 
DEX treatment, consecutive sections were prepared from TG samples at 1.5, 3, and 6 hours after 230 
DEX treatment and each section was stained with the bICP0 or VP16 specific antiserum.  At 3 231 
hours after DEX treatment, most VP16+ neurons were also bICP0+ (Figure 4A; double positive 232 
neurons denoted by arrows).  We also examined 1.5 and 6 hours after DEX treatment, and like 3 233 
hours after DEX treatment, nearly all VP16+ neurons were bICP0+ (Figure 4B).   234 
 235 
Sensory neurons that express bICP0 and VP16 frequently express the glucocorticoid 236 
receptor 237 
DEX, like the natural corticosteroids, binds and activates the glucocorticoid receptor 238 
(GR), reviewed in (13, 63).  Since GR is expressed in rat sensory neurons (8), we predicted that 239 
bICP0 and VP16 expression may be stimulated directly by DEX in neurons that express the GR.  240 
Support for this prediction comes from the finding that the bICP0 E promoter is stimulated by 241 
DEX in transient-transfection studies (81).  Thus, it was of interest to determine: 1) if the GR is 242 
expressed in a subset of bovine TG neurons, and 2) whether VP16+ and bICP0+ neurons express 243 
the GR. 244 
 245 
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Initial studies tested whether commercially available anti-serum recognizes the bovine 246 
GR. Antiserum directed against GR (MR-20; Santa Cruz Biotechnology) recognize mouse, rat, 247 
and human proteins were used for this study.  Western blots revealed that the GR antisera 248 
specifically recognized a protein with an approximate molecular weight of 90 kd in bovine 249 
kidney cells (CRIB) (Figure 5A, lane B) and mouse cells (lane M), which is the expected size of 250 
the GR (13, 63).  Confocal microscopy demonstrated that the antisera recognized a nuclear 251 
protein in CRIB cells following treatment with DEX (Figure 5B), which occurs when the GR 252 
binds DEX.  Prior to DEX treatment, the GR was localized throughout CRIB cells.  The GR 253 
antisera also recognized a subset of TG neurons after treatment with DEX for 3 hours (Figure 254 
5C).  In general, the signal localized to the nucleus suggesting the GR was activated after DEX 255 
treatment (denoted by arrows).  In uninfected bovine TG, the signal was generally disperse and 256 
not readily detected when compared to TG sections prepared from calves after DEX treatment.  257 
The signal appeared to be more concentrated in few neurons from mock-infected calves (denoted 258 
by arrows), which may have been the result of stress during transportation of calves to the 259 
necropsy room prior to euthanasia.   260 
 261 
Consecutive sections were prepared from calves treated with DEX and studies performed 262 
to determine if the GR was expressed in sensory neurons expressing bICP0 or VP16.  At 1.5 263 
hours after DEX treatment, GR+ and bICP0+ neurons were detected in certain areas of TG 264 
sections (Figure 6A; double positive neurons denoted by arrows).  We detected 71 GR+ and 265 
bICP0+ neurons: but only 2 that were GR+ but not bICP0+ and no bICP0+ neurons that were 266 
GR negative.  VP16+ and GR+ neurons were also readily detected at 1.5 hours after DEX 267 
treatment (Figure 6B; double positive neurons denoted by arrows).  GR+ neurons that were not 268 
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VP16+ were occasionally detected at 1.5 hours after DEX treatment (Figure 6B; neurons denoted 269 
by closed circles).  Seventy-two GR+ and VP16+ neurons were detected: but only two were 270 
identified in the same field that were just GR+.  At 1.5 hours after DEX treatment, no bICP0+ or 271 
VP16+ neurons were detected that were GR negative.   272 
 273 
DISCUSSION 274 
 In this study, two viral proteins that regulate transcription (VP16 and bICP0) were readily 275 
detected in sensory neurons within 1.5 hours after reactivation from latency was initiated with 276 
the synthetic corticosteroid DEX.  These two viral proteins were frequently detected in the same 277 
neuron.  In addition, neurons that expressed bICP0 or VP16 also frequently expressed the GR.  278 
Conversely, fewer neurons appeared to express the late proteins, gC and gD, before or after DEX 279 
treatment.  Although one could argue that we were unable to detect gC or gD in TG neurons 280 
because the antibodies were not as good as the VP16 or bICP0 antibodies used, the gC and gD 281 
antibodies clearly recognized a viral specific protein in formalin fixed cells prepared from 282 
productively infected bovine cells.  Furthermore, the gC and gD antibodies specifically 283 
recognized abundant levels of a viral specific protein during productive infection in a Western 284 
Blot.   285 
 286 
In general, stress increases corticosteroid levels, and activates the GR, which we predict 287 
is a molecular switch that can consistently initiate the escape from latency (see Figure 7 for a 288 
schematic of the events that are necessary for reactivation from latency).  During the escape from 289 
latency, several key events occur that result in lytic cycle viral gene expression.  First, specific 290 
DEX-induced cellular transcription factors stimulate certain viral promoters and productive 291 
infection (80). Secondly, lytic cycle viral gene expression, including bICP0 and VP16, may also 292 
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be stimulated directly by an activated GR.  Thirdly, DEX represses expression of LR (latency 293 
related) gene products (30, 60, 67), which is important because certain LR gene products can 294 
inhibit productive infection (2, 14, 30, 79).  Finally, apoptosis of T cells in TG that persist during 295 
latency occurs following DEX treatment of latently infected calves (73), which may enhance the 296 
incidence of reactivation from latency because CD8+ T cells are proposed to maintain latency (7, 297 
38, 40, 43, 44).  We predict that the pleiotropic effects of increased corticosteroids levels and 298 
activation of the GR lead to the escape from latency.   299 
 300 
DEX, as with other natural corticosteroids, specifically bind the GR and 301 
mineralocorticoid receptor (MR) (reviewed in (13)) resulting in nuclear localization of the GR or 302 
MR (58).  Nuclear GR or MR dimers stimulate transcription by binding consensus glucocorticoid 303 
response elements {GRE; 5’-GGTACANNNTGTTCT-3’} (16, 72). A GR or MR monomer can 304 
also stimulate transcription by binding to a GR ½ binding site, TGTTTCT or GGTACA, 305 
reviewed in (63).  Although it is possible that MR+ TG neurons promote reactivation from 306 
latency, we were unable to identify a commercially available antibody that recognizes the MR 307 
receptor in bovine cells (data not shown).  Within 5 minutes of glucocorticoid treatment, GR 308 
enters the nucleus, binds to glucocorticoid response elements, and induces rapid changes in 309 
chromatin conformation and transcriptional activation, reviewed in (5, 9).  The BHV-1 genome 310 
contains 58 GR ½ binding sites in 24 BHV-1 promoters (data not shown) and a previous study 311 
demonstrated that DEX stimulates the bICP0 early promoter in transient transfection assays (81). 312 
It will be of interest to directly test whether viral promoters are actually bound by a GR during 313 
the escape from latency.   314 
 315 
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In a small subset of latently infected neurons, DEX induced expression of bICP0 and/or 316 
VP16 is predicted to stimulate lytic cycle viral gene expression, productive infection, and 317 
production of infectious virus in a small subset of latently infected neurons (Figure 7).  Most 318 
neurons that escape latency do not produce infectious virus because they lack factors necessary 319 
for productive infection; consequently these neurons re-establish latency (60).  This study 320 
suggested that expression of late genes is one bottleneck that must be overcome to produce 321 
infectious virus.  It may not be necessary to produce high levels of late proteins; however 322 
expression of all late proteins necessary for producing infectious viruses would appear to be 323 
necessary.  Several sub-types of sensory neurons exist in TG (82), and certain subtypes of TG 324 
neurons are more permissive for HSV-1 and HSV-2 productive infection (1, 48, 82).  325 
Consequently, we predict that only certain neuronal subtypes, which are latently infected, can 326 
escape latency and have the necessary factors to activate expression of viral genes necessary to 327 
produce infectious virus.  An unanswered question that is raised as a result of these studies is: 328 
what is the threshold of corticosteroids that must be achieved to induce successful reactivation 329 
from latency?  Every day mammals encounter increases in corticosteroids, but those that are 330 
latently infected with their respective alpha-herpesvirinae subfamily member do not always 331 
successfully reactivate from latency, as judged by shedding of infectious virus.   332 
 333 
Published studies concluded that the normal cascade of viral gene expression in cultured 334 
cells is different than what occurs during the escape from latency.  For example, a late viral 335 
promoter (gC) is trans-activated by DEX inducible cellular transcription factors (SPDEF and 336 
Slug) (80) and Notch1 or Notch3 (79). Furthermore, the bICP0 E promoter, but not the bICP0 337 
and bICP4 IE promoter (IEtu1), is activated during reactivation from latency (81).  Finally, this 338 
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study demonstrated that VP16 (a late viral gene), but not gC or gD, is detected in TG neurons 339 
within 1.5 hours after latently infected calves are treated with DEX.  Several studies also suggest 340 
that the normal cascade of HSV-1 gene expression is different during reactivation from latency.  341 
For example, E gene expression and DNA replication is proposed to occur prior to IE gene 342 
expression (42, 52, 57, 68).  Another study concluded that expression of a late HSV-1 gene 343 
(VP16) promotes the exit from latency (70).  During explant induced reactivation from latency, 344 
viral gene expression was reported to be “disorganized” (10, 11).  It does not appear that BHV-1 345 
reactivation from latency is a random process in cattle because we consistently detected VP16 346 
and bICP0, but not gC or gD protein expression in TG neurons within 1.5 hours after DEX 347 
treatment.   348 
 349 
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 599 
Figure Legends 600 
Figure 1.  Analysis of BHV-1 protein expression in productively infected cells. 601 
Panel A:  Western blot analysis comparing the expression of BHV-1 genes following 602 
infection of bovine CRIB cells.  Monolayers of CRIB cells were mock infected or infected with 603 
BHV-1 (moi=2) in the presence or absence of 400 μg/ml of phosphonoacetic acid (PAA).  At the 604 
designated times after infection (hours), whole cell lysate was prepared.  A total of 50 μg of 605 
protein was separated in an 8% SDS-PAGE gel and viral proteins were detected by Western blot 606 
analysis using antibodies specific for the designed BHV-1 genes.  β-actin protein levels were 607 
analyzed in the respective samples as a loading control. The position of molecular weight 608 
markers for the respective panels is denoted.  Molecular weight mass of the markers is shown on 609 
the right (kDa).  The approximate molecular weight (kDa) of bICP0 is 97, VP16 is 65, gC is 95, 610 
and gD is 77.  611 
 612 
Panel B:  Subcellular localization of viral proteins in productively infected cells.  Confocal 613 
microscopy was performed to detect BHV-1 proteins in CIRB cells infected with BHV-1 614 
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(moi=2) for 20 hours and then fixed with formalin.  Mock infected CIRB cells served as a 615 
control.  Fixed cells were incubated with antibodies specific for the designed viral genes. An 616 
Alexa Fluor 488 goat anti-rabbit secondary antibody (green) or Alexa Fluor 633 goat anti-mouse 617 
antibody (red) was used to detect viral protein expression.  Images were obtained with Bio-Rad 618 
confocal laser-scanning microscope (MRC-1024ES) with excitation/emission at 488/520 nm.  619 
Nuclear DNA (blue) was stained with DAPI (4',6-diamidino-2-phenylindole).  Merged images 620 
are shown and they are representative of three independent experiments. 621 
 622 
Figure 2.  bICP0 and VP16 are expressed in sensory neurons following DEX treatment to 623 
induce reactivation from latency.   624 
IHC was performed using the bICP0 or VP16 antibody as described in the materials and methods.  625 
Arrows denote neurons that were recognized by the respective antibody.  Magnification is 626 
approximately 400x. 627 
 628 
Figure 3.  The glycoproteins gC and gD are weakly expressed in sensory neurons following 629 
DEX treatment to induce reactivation from latency.   630 
IHC was performed using the gC or gD specific antibody as described in the materials and 631 
methods using TG sections from latently infected calves (latency), 1.5, 3, or 6 hours after DEX 632 
treatment.  Arrows denote neurons that were recognized by the respective antibody.  633 
Magnification is 400x. 634 
 635 
Figure 4.  bICP0 and VP16 are frequently expressed in the same neuron following DEX 636 
induced reactivation from latency.   637 
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Panel A:  Consecutive sections were cut from formalin fixed paraffin embedded TG from calves 638 
latently infected with BHV-1 that were treated with DEX for 3 hours.  IHC was performed using 639 
the bICP0 antibody on one section and the VP16 antibody was used to stain the consecutive 640 
section.  Arrows denote neurons that were recognized by the respective antibody.  Magnification 641 
is 400x. 642 
Panel B:  The number of bICP0+ and VP16+ neurons (double positive) is shown for 1.5, 3, and 643 
6 hours after DEX treatment (black columns).  The number of VP16+ neurons (white columns) 644 
or bICP0+ (grey columns) are also shown at the designated times after DEX induced reactivation 645 
from latency.   646 
 647 
Figure 5.  Detection of GR in bovine kidney cells (CRIB) 648 
Panel A:  Bovine cells (CRIB) or mouse neuroblastoma cells (Neuro-2A) (30 ug protein/lane) 649 
were electrophoresed in a SDS PAGE gel, and Western Blot analysis performed using the 650 
commercially available GR antibody (Santa Cruz: H-300).  Lanes denoted B were cell lysate 651 
prepared from bovine kidney cells (CRIB) and lanes denoted M were cell lysate from mouse 652 
neuroblastoma cells (Neuro-2A).   653 
Panel B:  Cells were treated with DEX and immunofluorescence performed as described in the 654 
materials and methods.  As controls, certain cultures were not treated with DEX.  Localization of 655 
the GR was examined by immunofluorescence.  Nuclear DNA was identified by DAPI staining.   656 
 657 
Panel C:  IHC was performed with TG samples from uninfected calves and three hours after 658 
DEX treatment using procedures described in the materials and methods.  Arrows denote the 659 
GR+ neurons.  Magnification is approximately 400x.   660 
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 661 
Figure 6.  GR+ neurons frequently express bICP0 or VP16 during the escape from latency.   662 
Consecutive sections were cut from formalin fixed paraffin embedded TG from calves latently 663 
infected with BHV-1 that were treated with DEX for 1.5 hours.  IHC was performed using the 664 
bICP0 antibody on one section and the GR antibody on the adjacent section (Panel A).  IHC was 665 
performed using the VP16 antibody on one section and the GR antibody on the adjacent section 666 
(Panel B).  Arrows denote neurons that were recognized by the respective antibody.  Closed 667 
circles denote GR+ neurons that were VP16 negative.  Magnification is 400x. 668 
 669 
Figure 7.  Putative steps that occur during DEX induced escape from latency.   670 
For details, see the discussion.   671 
 672 







